Health · Full coverage
Startup Uses Personalized Scent Technology to Treat Sleep Problems
How 3 Israeli newsrooms covered this story — translated into English and compared side by side.
100% center
Center 2Unrated 1
First reported by N12 · Jun 16, 2026
What happened
Kimba, a startup founded by Ben Foxbrunner and Gabi Beck, raised $6.5 million to market an AI sleep device that uses personalized scent therapy. The company says clinical studies showed improved sleep and cognition, and it is already selling in the U.S. with an Israel launch planned.
- 01Kimba raised $6.5 million in seed funding for AI-based scent therapy.
- 02Founder Ben Foxbrunner built the product after PTSD and chronic insomnia.
- 03The system is sold in the U.S. for $299 and will soon launch in Israel.
- 04A 50-person study found 21% better cognition and 86% reported improved sleep.
- 05Two additional Israeli clinical studies are now testing the technology.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 3 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Israeli Startup Remepy Raises $36 Million to Develop AI-Driven Hybrid Drugs2 days agoIsraeli Startup Hemispheric Raises $52 Million to Launch AI Brainwave Analysis ModelJul 15, 2026Israeli Biotech Leader Daphne Zohar Advances Depression Drug Market After Major ExitJul 17, 2026Israeli Startup QuantHealth Raises $45 Million to Revolutionize Drug Development with AIAug 5, 2026Israeli AI Founder Maor Shlomo Launches Private Cancer Research Investment FundJul 30, 2026Israeli Innovation Authority Leads $70 Million AI Consortium for Personalized MedicineJul 12, 2026
